Generic Name and Formulations:
Azelaic acid 15%; aqueous gel; contains propylene glycol.
Indications for FINACEA:
Wash and dry skin. Massage thin layer gently into affected areas twice daily (AM & PM). May apply cosmetics after gel dries.
Monitor patients with dark complexions for hypopigmentation. Discontinue if sensitivity or severe irritation develops. Avoid eyes, mouth, other mucous membranes, occlusive dressings, topical alcoholic products, abrasives, peeling agents. Reevaluate if no improvement after 12 weeks of treatment. Foam: flammable. Pregnancy (Cat.B). Nursing mothers.
Burning, stinging, tingling, pruritus, scaling, dry skin, xerosis, erythema, irritation, edema, contact dermatitis, acne; worsening of asthma; foam: also application site pain.
Gel—50g tubes; Foam—50g cans
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis